Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Pharmacy News:
12/10/20 mb Regeneron Mab Cocktail Education
December 10, 2020
From: "Madeline Belk" <madeline.belk@hhsys.org>
Sent: Wednesday, December 9, 2020 6:28:33 PM
Subject: Regeneron Mab Cocktail Education
Casirivimab and imdevimab preparation and storage education
Pharmacists,
We now have the Regeneron monoclonal antibody cocktail (casirivimab and imdevimab). It is very similar to the Eli Lilly product (bamlanivimab) in regards to indication, mechanism, adverse effects, and monitoring. However, the preparation and storage are slightly different. Attached you will find a guidance document regarding these aspects of the medication.
Please reach out if you have any questions.
We now have the Regeneron monoclonal antibody cocktail (casirivimab and imdevimab). It is very similar to the Eli Lilly product (bamlanivimab) in regards to indication, mechanism, adverse effects, and monitoring. However, the preparation and storage are slightly different. Attached you will find a guidance document regarding these aspects of the medication.
Please reach out if you have any questions.